- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Poniard Pharmaceuticals Inc (PARD)
Poniard Pharmaceuticals Inc stock price live, this page displays OTC PARD stock exchange data. View the PARD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Poniard Pharmaceuticals Inc real time stock price chart below.
What Is the Poniard Pharmaceuticals Inc Stock Price Today?
The Poniard Pharmaceuticals Inc stock price today is 0.000.
What Is the Stock Symbol for Poniard Pharmaceuticals Inc?
The stock symbol for Poniard Pharmaceuticals Inc is ""PARD.""
What Stock Exchange Does Poniard Pharmaceuticals Inc Trade On?
Poniard Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Poniard Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Poniard Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PARD quote. (ISIN: US7324494001)
What Is the Poniard Pharmaceuticals Inc Stock Price Today?
The Poniard Pharmaceuticals Inc stock price today is 0.000.
What Is the Stock Symbol for Poniard Pharmaceuticals Inc?
The stock symbol for Poniard Pharmaceuticals Inc is ""PARD.""
What Stock Exchange Does Poniard Pharmaceuticals Inc Trade On?
Poniard Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Poniard Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Poniard Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PARD quote. (ISIN: US7324494001)
OTC Markets
Currency in USD
0.000
0.000(0.00%)
Closed·
Fair Value
An estimate of a Poniard Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.000
0.000
52 wk Range
0.000
0.010
PARD Scorecard
Full Analysis
Stock generally trades with low price volatility
PARD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Poniard Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0000.000
52 wk Range
0.0000.010
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PARD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Poniard Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Poniard Pharmaceuticals Inc Company Profile
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.
Compare PARD to Peers and Sector
Metrics to compare | PARD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPARDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.2x | −0.6x | |
PEG Ratio | 0.00 | −0.03 | 0.00 | |
Price/Book | 0.0x | 2.3x | 2.6x | |
Price / LTM Sales | 0.0x | 8.9x | 3.3x | |
Upside (Analyst Target) | 0.0% | 211.1% | 39.1% | |
Fair Value Upside | Unlock | 0.4% | 4.5% | Unlock |
Earnings
Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Poniard Pharma Trade On?
Poniard Pharma is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Poniard Pharma?
The stock symbol for Poniard Pharma is "PARD."
What Is the Poniard Pharma Market Cap?
As of today, Poniard Pharma market cap is 149.00.
What Is Poniard Pharma's Earnings Per Share (TTM)?
The Poniard Pharma EPS (TTM) is -3.79.
From a Technical Analysis Perspective, Is PARD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Poniard Pharma Stock Split?
Poniard Pharma has split 3 times.
How Many Employees Does Poniard Pharma Have?
Poniard Pharma has 8 employees.
What is the current trading status of Poniard Pharma (PARD)?
As of 19 Aug 2025, Poniard Pharma (PARD) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.01 to 0.01.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.